• Open Science Drug Discovery Partnership, READDI, Aims to Invest $125 Million to Prevent Future Pandemics

    1 month ago - By UNC Healthcare

    The Rapidly Emerging Antiviral Drug Development Initiative involves researchers from the UNC School of Medicine, the UNC Eshelman School of Pharmacy, and the UNC Gillings School of Global Public Health.
    Read more ...